In prostate cancer, Mao-A plays an oncogenic role by promoting tumor development and metastasis [30], while Mao-B activity decreases in prostate cancer tissues, correlating with favorable clinical outcomes. This evidence concerns the gene MAOA and prostate carcinoma.